Immuron Limited (IMC) is a biopharmaceutical company in Australia. IMC’s product ranges target infectious diseases of the gastrointestinal tract, chronic diseases such as fatty liver (NASH), and prevention of influenza. IMC currently has one product in the market and seven products under research and development process.
IMC – Immuron Limited
Be the first to comment